Price Position and Structural State
MRNAUSDT (MRNA) closed at 213.05 USDT on October 12, 2026, down 5.13%. The asset now sits in a sideways structure near the top of its 55-day range. Current 55-day support is near 130.5 USDT, with resistance near 234.31 USDT. A daily close above 234.31 USDT would confirm an upside regime shift. A rejection near resistance would keep price inside the range.
Moving Averages and Trend Context
MRNA is trading above the available moving averages. MA9 at 206.787 USDT stands as the first support area to watch. Long-term moving-average history is still forming, so the most reliable reads come from current price structure and shorter-term moving-average support. Once MA100 and MA200 establish, the trend read will carry more historical context.
Trading Friction and Price Efficiency
MRNA shows moderate trading friction, with a 3-day friction score of 52.7. The score combines price progress, wick rejection, and volume confirmation. Recent candles show mixed acceptance, so price is moving but still showing some noise. Moves near support or resistance need a cleaner daily close before they carry stronger weight.
Open Interest, Funding, and Positioning
Open interest fell -1.25% in one day but remains near the upper side of its 180-day range. This shows leverage is still elevated, even though some positions were reduced.
Funding is near neutral across the 24-hour and 7-day averages, at 0.000000% and +0.001642%. This shows limited cost pressure on either side, so funding is not giving a strong directional signal right now.
The long/short ratio is 0.70, sitting near the lower side of its 180-day range at 4.63%. This means short accounts dominate, with the long/short reading near the low side of recent history.
Correlation, Beta, and Index Relationship
MRNA shows weak linkage to the broader crypto market (Sigloid Index). Correlation is limited, and R² indicates that index behavior explains only a small portion of its movement. This suggests price action is largely driven by asset-specific factors rather than broader market direction. Over the 30-day window, the relationship is stable.
| Window | Correlation | Beta | R² | Read |
|---|---|---|---|---|
| 30D | 0.228 | 0.376 | 0.052 | Weak linkage |
| 60D | — | — | — | Not enough data |
| 180D | — | — | — | Not enough data |
Momentum, Volatility, and Indicator Pressure
MRNA's volatility profile is controlled rather than stretched. ATR% reads 6.10, near the lower side of its full historical range. Bollinger Band width% reads 24.69, near the middle of its full historical range. 20-day Volume Z-score is 0.90. Range expansion is not leading the setup right now.
Momentum is stronger. RSI is 60.00, ROC14 is +7.78%, and MACD histogram is positive. These readings point in the same direction: upside pressure is active across momentum and multi-day acceleration.
The read is still incomplete: momentum is improving, but volatility or participation has not confirmed the move strongly enough.
Broader Market Regime
The Sigloid Index remains in a sideways regime, showing no clear broad market direction. MRNA has a weak link to that market condition, so price behavior depends mainly on asset specific structure rather than the broader market.
Key Levels for the Next State Change
For MRNA, the next structural shift depends on range boundaries. A daily close above 55-day resistance at unavailable establishes a bullish regime, while a daily close below 55-day support at unavailable confirms a bearish regime.